Cervical cancer is one of the most preventable forms of cancer. However, each year in the United States, an estimated 13,000 new cases of cervical cancer are diagnosed and 4,000 women die of this cancer, according to the Centers for Disease Control and Prevention. Screening tests and the HPV vaccine are the keys to prevention. When cervical cancer […]
Tag Archives: GenPath Women’s Health
Press Release
BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings
09
Feb
Feb
CINtec® PLUS Cytology offered as a reflex test when cytology is NILM and HPV positive ELMWOOD PARK, NJ, February 9, 2023 – BioReference® Health LLC, one of the largest full-service specialty laboratories in the United States, announced today it will be one of the first commercial laboratories to use offer the CINtec® PLUS Cytology test from […]
13
Dec
Dec
This December, BioReference is proud to be celebrating an exciting milestone – our 40th anniversary. For over four decades, our dedicated team has worked to build a legacy of scientific expertise through innovative and tailored laboratory test solutions. Join us in celebrating our 40th anniversary and learn more about our dynamic evolution. BioReference Celebrates 40 […]
